Publications, Pharmaceutical

Delivering On The Promises of Intranasal Vaccination

Intranasal vaccination offers a number of valuable benefits. Nasal vaccines are easy to self-administer, non-invasive and trigger a broad immune response, notably mucosal immunity. This article reviews the advantages of intranasal vaccination, the challenges associated with developing nasal spray vaccines and recent advances in the field. COVID-19 has had a hugely disruptive impact on the vaccines market. Although only four nasal spray vaccines are currently in commercial use a significant number of intranasal spray vaccines for COVID-19 are in development, holding out the promise of adding mucosal immunity to improve resistance to the virus. Device design and emerging strategies for successful vaccine formulation are discussed.

Download Publication
Author(s): Dr. Julie Suman Nektaria Karavas
18 Nov 2021

This Might Also Be of Interest

25 Apr 2022

Nasal Drug Development, Trends and Challenges with Nasal Formulat...

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
22 Apr 2022

Nose to Brain Drug Delivery – A Promising Future

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
21 Apr 2022

Nasal Drug Delivery, Trends, Challenges and Opportunities for The...

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
25 Feb 2022

From Formulation to Patient – Intranasal Administration of ...

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 13
Back To Top